More sunshine as a baby linked to less disease activity for children with multiple sclerosis
Getting at least 30 minutes of daily summer sun in the first year of life may mean a lower relapse risk for children who are ...
lupus.bmj3h
Time trends of variability in disease activity in systemic lupus erythematosus
Objective Disease activity both between and within patients with SLE is highly variable, yet factors driving this variability remain unclear. This study aimed to identify predictors of variability in ...
BioPharma Dive5h
Biogen inks royalty deal to gain funding for lupus drug R&D
The agreement hands Biogen as much as $250 million in exchange for milestone payments and sales royalties for litifilimab, ...
lupus.bmj9h
Association of race and ethnicity with mortality in adults with SLE: a systematic literature review and meta-analysis
Objectives Ethnicity and health outcomes are intrinsically interrelated, although mechanisms are complex. SLE is a disease ...
FierceBiotech10h
Biogen enlists Royalty for pursuit of lupus crown, securing $250M to fund phase 3 program
Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...
WHO, St. Jude launch international delivery of childhood cancer medicines
A child’s chances of surviving cancer are largely determined by where they are born,” said James R. Downing, MD, president and CEO of St. Jude.
Natural killer cells offer hope for hard-to-treat pediatric sarcomas
University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...